United Kingdom· GB-APID-31014611000001101
Eperzan 50mg powder and solvent for solution for injection pre-filled pens
A albiglutide product containing albiglutide, registered in United Kingdom by GlaxoSmithKline UK Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Albiglutide is registered in 2 of 19 countries.
Countries holding a registration under ATC A10BJ04 (albiglutide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Albiglutide · ATC A10BJ04
2 / 19 countries
- Finlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Albiglutide
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A10BJ04
- ATC class
- Albiglutide
- Defined daily dose
- 5.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5000123114337
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
306 interactions on record for albiglutide.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Albiglutide · interactions on record
306 records
- 3 severe
- 259 moderate
- 44 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Albiglutide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/39a4218f-c556-40e8-853e-c4e449a10b40 GET /v1/drugs/39a4218f-c556-40e8-853e-c4e449a10b40?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "31014611000001101",
"desc": "Eperzan 50mg powder and solvent for solution for injection pre-filled pens (GlaxoSmithKline UK Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "31015811000001101",
"source": "dmd",
"vtm_id": "774449006",
"strength": "50 mg",
"substance": "Albiglutide",
"ingredient": "Albiglutide",
"supplier_code": "4012301000001105"
}See everything about albiglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.